[Indications and results of exclusive radiotherapy in early prostatic adenocarcinoma] (Q74547651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

[Indications and results of exclusive radiotherapy in early prostatic adenocarcinoma] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

P Bey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

431-438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Should brachytherapy be considered a therapeutic option in localized prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

External beam radiation therapy does not offer long-term control of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Long-term control of prostate cancer with radiation. Past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy: the need for improved systemic and locoregional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Potential benefit of improved local tumor control in patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year results

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

A pathologist's view of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Late GI and GU complications in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

1 reference

7 January 2021

Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989564-9

7 January 2021

10.1016/S1278-3218(97)89564-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9587373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference